Cargando…

Impact of the Renin-Angiotensin System on the Pathogeny and Pharmacotherapeutics of Neurodegenerative Diseases

Brain neurodegenerative diseases (BND) are debilitating conditions that are especially characteristic of a certain period of life and considered major threats to human health. Current treatments are limited, meaning that there is a challenge in developing new options that can efficiently tackle the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bild, Walther, Vasincu, Alexandru, Rusu, Răzvan-Nicolae, Ababei, Daniela-Carmen, Stana, Aurelian Bogdan, Stanciu, Gabriela Dumitrița, Savu, Bogdan, Bild, Veronica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599929/ https://www.ncbi.nlm.nih.gov/pubmed/36291638 http://dx.doi.org/10.3390/biom12101429

Ejemplares similares

Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia
por: Ababei, Daniela-Carmen, et al.
Publicado: (2023)

Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty
por: Vasincu, Alexandru, et al.
Publicado: (2022)

The Impact of Some Modulators of the Renin–Angiotensin System on the Scopolamine-Induced Memory Loss Mice Model
por: Ababei, Daniela-Carmen, et al.
Publicado: (2023)

Exploring the Involvement of the Amyloid Precursor Protein A673T Mutation against Amyloid Pathology and Alzheimer’s Disease in Relation to Therapeutic Editing Tools
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2022)

Self-Medication in Rural Northeastern Romania: Patients’ Attitudes and Habits
por: Rusu, Razvan-Nicolae, et al.
Publicado: (2022)

Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2020)

Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and Diabetes
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2021)

Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2019)

Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity
por: Vasincu, Alexandru, et al.
Publicado: (2023)

Renal Contributions in the Pathophysiology and Neuropathological Substrates Shared by Chronic Kidney Disease and Alzheimer’s Disease
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2020)

Relevance of Surface Neuronal Protein Autoantibodies as Biomarkers in Seizure-Associated Disorders
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2019)

From Evidence to Clinical Guidelines in Antibiotic Treatment in Acute Otitis Media in Children
por: Spoială, Elena Lia, et al.
Publicado: (2021)

Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
por: Filipiuc, Leontina Elena, et al.
Publicado: (2021)

Preclinical Studies of Canagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, and Donepezil Combined Therapy in Alzheimer’s Disease
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2023)

Intracerebroventricular Coadministration of Protoxin-II and Trace Elements in Rats Enhances the Analgesic Effect of the 1.7 Voltage-Gate Sodium Channel Blocker
por: Stanciu, Gabriela-Dumitrita, et al.
Publicado: (2019)

Pathogeny of Diabetes
Publicado: (1911)

Pathogeny of Gastric Ulcer
Publicado: (1887)

Medicinal Plants of the Family Lamiaceae in Pain Therapy: A Review
por: Uritu, Cristina M., et al.
Publicado: (2018)

A Priori Reasoning as to Pathogeny
Publicado: (1917)

Renin–angiotensin system gene expression and neurodegenerative diseases
por: Goldstein, Benjamin, et al.
Publicado: (2016)

Vernonia kotschyana Roots: Therapeutic Potential via Antioxidant Activity
por: Vasincu, Alexandru, et al.
Publicado: (2014)

Acute Toxicity and Pharmacokinetic Profile of an EU-GMP-Certified Cannabis sativa L. in Rodents
por: Filipiuc, Leontina-Elena, et al.
Publicado: (2023)

Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics
por: Sharifi-Rad, Mehdi, et al.
Publicado: (2020)

Involvement of Leishmania Phosphatases in Parasite Biology and Pathogeny
por: Freitas-Mesquita, Anita Leocadio, et al.
Publicado: (2021)

Some Observations on the Pathogeny and Treatment of Pes Cavus, Etc.
por: Clarke, J. Jackson
Publicado: (1902)

On the Nature and Pathogeny of Malignant Jaundice According to Recent Works
por: Mathieu, Albert
Publicado: (1880)

Correlations between Cognitive Evaluation and Metabolic Syndrome
por: Oprescu, Andrei Cătălin, et al.
Publicado: (2023)

Amyloidosis in Alzheimer’s Disease: Pathogeny, Etiology, and Related Therapeutic Directions
por: Ma, Chen, et al.
Publicado: (2022)

Multiple Aspects of Inappropriate Action of Renin–Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases
por: Szczepanska-Sadowska, Ewa, et al.
Publicado: (2022)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

EXPERIMENTAL ARTHRITIS IN THE RABBIT. A CONTRIBUTION TO THE PATHOGENY OF ARTHRITIS IN RHEUMATIC FEVER
por: Faber, Harold Kniest
Publicado: (1915)

Pathogénie de la maladie de Kawasaki : quoi de neuf ?
por: Belot, Alexandre, et al.
Publicado: (2012)

A Lecture on Some Points in the Clinical History and Pathogeny of Locomotor Ataxy
por: Clymer, Meredith
Publicado: (1870)

The Renin-Angiotensin System Textbook
por: Cumming, Allan D
Publicado: (1994)

Brain renin angiotensin in disease
por: Phillips, M. Ian, et al.
Publicado: (2008)

Pathogeny of cerebral venous thrombosis in SARS-Cov-2 infection: Case reports
por: Guendouz, Cécile, et al.
Publicado: (2021)

Secondary Metabolites from Plants Possessing Inhibitory Properties against Beta-Amyloid Aggregation as Revealed by Thioflavin-T Assay and Correlations with Investigations on Transgenic Mouse Models of Alzheimer’s Disease
por: Stefanescu, Raluca, et al.
Publicado: (2020)

Pharmacotherapeutic targets in Alzheimer's disease
por: Biran, Yif'at, et al.
Publicado: (2009)

Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System
por: Konoshita, Tadashi
Publicado: (2011)

Mycobacterium tuberculosis and Pulmonary Rehabilitation: From Novel Pharmacotherapeutic Approaches to Management of Post-Tuberculosis Sequelae
por: Meca, Andreea-Daniela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nihe82n1u2gpjvhnuaqj9hqkir